Statistical approaches to interim monitoring of medical trials: A review and commentary
From MaRDI portal
Publication:1596008
DOI10.1214/ss/1177012099zbMath0955.62640OpenAlexW2031177648MaRDI QIDQ1596008
Christopher Jennison, Bruce W. Turnbull
Publication date: 7 February 2001
Published in: Statistical Science (Search for Journal in Brave)
Full work available at URL: https://doi.org/10.1214/ss/1177012099
Applications of statistics to biology and medical sciences; meta analysis (62P10) Sequential statistical analysis (62L10)
Related Items
Approximations for non-symmetric truncated sequential and repeated significance tests ⋮ CONDITIONAL PROBABILITY OF SIGNIFICANCE FOR EARLY STOPPING IN FAVOR OFH0 ⋮ Bayesian Inference Is Unaffected by Selection: Fact or Fiction? ⋮ Type I error probability spending for post-market drug and vaccine safety surveillance with Poisson data ⋮ Some topics of current interest in clinical trials ⋮ Three-stage designs for monitoring clinical trials ⋮ On the curtailment of sampling ⋮ Finding confidence bound using two-stage data ⋮ Comparison of conditional power criteria for early termination of clinical trials ⋮ Testing Secondary Hypotheses Following Sequential Clinical Trials ⋮ Sequential design and analysis in the randomized clinical trial: A historical perspective ⋮ Odds ratio-based group sequential analysis for joint binomial and inverse binomial sampling ⋮ Interim analysis of clinical trials based on urn models ⋮ Unnamed Item ⋮ Incorporation of a stopping criterion for futility into the design of a clinical trial with one interim analysis ⋮ ESTIMATION FOLLOWING EXTENSION OF A STUDY ON THE BASIS OF CONDITIONAL POWER